Exhibit 10.98

                           ADVISORY SERVICES AGREEMENT

THIS Agreement ("Agreement"), effective as of September 1, 2007 is entered into
by and between Gene Logic Inc. ("GLGC"), with a place of business at 50 West
Watkins Mill Road, Gaithersburg, Maryland 20878, and Louis Tartaglia, whose
address is at 32 Manor House Road, Newton, MA. 02459 ("Adviser").

     In consideration of the representations and agreements contained herein,
Adviser and GLGC agree as follows:


     1.  Purpose: GLGC is in the business of providing services to the
         pharmaceutical and biotechnology industries. Such services are provided
         in part through GLGC's Drug Repositioning Division, which uses its drug
         indication discovery platform to identify and develop new or expanded
         uses for small molecule therapeutics. Potential alternative therapeutic
         uses are then validated through animal studies and may then be further
         developed and tested with the goal of commercializing such new uses
         discovered by GLGC. The Drug indication discovery platform may also
         have other potential uses, such as to expand indications for customers'
         currently marketed drugs, and prioritize and identify new or confirm
         known indications for compounds. These activities are collectively
         referred to herein as GLGC's Drug Repositioning business.

         Adviser was previously the General Manager of GLGC's Drug Repositioning
         Division and has special expertise in the field of drug repositioning.
         GLGC wishes to obtain advisory services from Adviser and Adviser is
         willing to provide services to GLGC. The purpose of this Agreement is
         to establish the terms upon which such services will be provided.

     2. Services.

              a.  Subject to the terms and conditions of this Agreement, GLGC
                  hereby appoints Adviser as a special adviser to its Drug
                  Repositioning business and Adviser hereby accepts such
                  appointment.
              b.  Adviser agrees that, during the term of this Agreement and any
                  subsequent extension thereto, he will provide his services as
                  requested by GLGC's Chief Executive Officer ("CEO"), Drs.
                  Thomas Barnes and Stephen Donahue or Bethany Mancilla in their
                  roles as executives in GLGC's Drug Repositioning business or
                  any other executive at GLGC designated by the CEO.
              c.  As requested with respect to GLGC's Drug Repositioning
                  business, in conjunction with GLGC's Board of Directors and
                  members of GLGC's senior management team, Adviser will,

                         i.   evaluate strategic alternatives;
                         ii.  recommend strategic policy decisions;
                         iii. critique proposed strategic initiatives;
                         iv.  refer GLGC to potential new business opportunities
                              appropriate to the Drug Repositioning business;
                         v.   introduce and facilitate new business and
                              financial connections intended to facilitate
                              development of the Drug Repositioning business;
                         vi.  participate in any relevant discussions/meetings
                              with GLGC partners or customers;
                         vii. advise on scientific data interpretation and
                              presentation;
                         viii. otherwise advise GLGC with respect to GLGC's Drug
                              Repositioning activities; and
                         ix.  provide such other services as may be mutually
                              agreed by the parties


<PAGE>

              d.  The services may be provided by meetings or by telephone,
                  e-mail or other written communication. If requested, Adviser
                  will meet or communicate with GLGC representatives or
                  customers of GLGC at times and places to be mutually agreed.

              e.  Adviser shall provide services to GLGC based on the
                  proprietary and/or confidential information provided by GLGC
                  and/or developed by Adviser in the course of providing
                  services hereunder and shall devote such time as reasonably
                  necessary to provide the requested services. Subject to the
                  provisions of Section 10, Adviser agrees to perform the
                  services in a timely and professional manner consistent with
                  industry standards.

     3. Compensation.

              a.  In consideration for the services during the term of this
                  Agreement and while this Agreement is in force, Adviser shall
                  receive:

                         i.   a retainer at a rate of $25,000 per year payable
                              in arrears in quarterly installments, and
                         ii.  payment for specific services at a rate of
                              one-hundred-fifty dollars ($150.00) per hour of
                              Adviser's time devoted to providing services, but
                              not more than $1,200 per day.

                  Adviser shall submit an invoice for his services to GLGC on a
                  monthly basis within thirty days after the end of each month
                  in which services are provided hereunder, showing by date the
                  hours worked, the services provided and the GLGC executive
                  with or for whom the work was performed. GLGC shall pay
                  Adviser for his services within thirty (30) days of receiving
                  each invoice. Adviser will obtain CEO's prior written approval
                  if the hourly rate compensation for services provided in any
                  calendar month are expected to exceed $4,000.00, before
                  providing services that exceed such limit.
              b.  Adviser will also be reimbursed for all reasonable and
                  necessary out-of-pocket expenses (including travel, lodging,
                  and the like), which are incurred at the request of and
                  approved in writing in advance by GLGC, provided any travel
                  expenses comply with GLGC's travel policy, a copy of which is
                  available upon request.

     4.  Confidentiality. In view of GLGC's proprietary rights and interests
         concerning its facilities and technology, Adviser agrees that during
         the term of this Agreement and any subsequent extension(s) thereto and
         for a period of five (5) years thereafter, Adviser agrees to keep
         strictly confidential and not use for his own benefit or for the
         benefit of any third party any information which he may acquire
         relating to GLGC's business, whether such information is disclosed or
         made known by GLGC to Adviser or is generated by Adviser in the course
         of performing the services hereunder. By way of illustration and not
         limitation, such shall include all information, communicated by any
         means, relating to the business of GLGC that is not available to the
         general public, including its technical and business information,
         assets, inventions, know-how, research programs, biological materials,
         processes, drug compound hypotheses, designs, trade secrets, contracts,
         improvements, discoveries, databases, software programs, development
         tools, budgets and unpublished financial information, licenses, and
         other data, both technical and non-technical, prospects, protocols, and
         other information associated with this Agreement and the methods by
         which GLGC uses its indication seeking technologies.

         Adviser shall not disclose such information to any third party or use
         such information for any purpose, except as provided herein, without
         the prior written approval of GLGC. Adviser shall have no obligation
         with respect to any portion of such information which:


<PAGE>

              a.  is or later becomes generally available to the public by use
                  publication or the like, through no fault of Adviser;
              b.  is obtained from a third party who had the legal right to
                  disclose the same to Adviser and who is not under an
                  obligation of confidentiality to GLGC; or
              c.  Adviser already possesses, as evidenced by written records,
                  predating receipt thereof from GLGC provided that this
                  exception shall not apply to any information received or
                  developed by Adviser during his prior employment by GLGC or by
                  Millennium Pharmaceuticals, Inc and its affiliates to the
                  extent that such information subsequently became the property
                  of GLGC and was confidential at the time it became the
                  property of GLGC.

         Specific information disclosed to Adviser by GLGC shall not be deemed
         to be available to the public or in prior possession of Adviser merely
         because such specific information is embraced by more general
         information available to the public or in prior possession of Adviser.

         Adviser also acknowledges that the confidential information to which he
         may have access as a result of the relationship with GLGC described
         herein may constitute material non-public information and that he may
         not trade in the securities of GLGC or assist others to do so on the
         basis of such material non-public information and that he may not
         disclose such information to third parties who might trade on such
         information.

     5.  New Developments. Adviser agrees that any information, including but
         not limited to discoveries, inventions, innovations, suggestions,
         know-how, ideas and reports made by Adviser which either results from
         information disclosed by GLGC, or is developed as a result of Adviser's
         services under this Agreement ("New Developments"), shall become the
         sole property of GLGC without further compensation to Adviser and shall
         be promptly disclosed to GLGC. Adviser will treat such new developments
         as information which is subject to the confidentiality provisions of
         Paragraph 3 herein. GLGC shall own all right, title and interest in and
         to all New Developments under this Agreement.

     6.  Patent Rights and Licenses. If patentable subject matter results from
         services provided hereunder, Adviser shall assist GLGC in the
         preparation and prosecution of appropriate patent applications and
         shall without further compensation execute appropriate documents
         acknowledging the assignment of his rights in such subject matter and
         applications to GLGC. All expenses incidental to the filing and
         prosecution of any such patent applications shall be borne by GLGC. The
         disclosure of proprietary information by GLGC to Adviser shall not
         result in any obligation to grant Adviser any rights in and to said
         proprietary subject matter.

     7.  Third-Party Confidential Information. Adviser agrees that during the
         term of this Agreement, he will not disclose to GLGC any information
         that is confidential or proprietary to any third party.

     8.  Non-Compete/Non-Solicitation. While this Agreement is in effect and for
         one year after this Agreement ends, Adviser agrees that he will not
         assist third parties to develop, market or sell Drug Repositioning
         services to be offered to pharmaceutical and/or biotechnology companies
         as a service or as a collaborative arrangement or in any similar
         relationship that will compete in the marketplace with GLGC's Drug
         Repositioning business. Adviser further agrees that, during the term of
         this Agreement and for one (1) year after the date of termination of
         the Agreement regardless of the reason for termination, Adviser will
         not induce or solicit any employee of GLGC to leave the employ of GLGC
         or assist any third party to do so.

     9.  Term and Termination. This Agreement shall be effective for a
         twelve-month period beginning as of September 1, 2007, and may be
         extended in writing by mutual consent of the parties. However, either
         party may terminate this Agreement at any time upon sixty (60) days'
         prior written notice. Any rights or obligations set forth herein which
         are accrued prior to the termination of this Agreement as well as any
         sections intended by their nature to survive, including but not limited
         to Sections 4, 5, 6 and 8, shall survive termination or expiration of
         this Agreement. Upon termination or expiration of this Agreement,
         Adviser shall promptly return to GLGC all GLGC documentation, property,
         data and related information, along with any copies thereof.


<PAGE>

     10. Other Employment. Adviser is a principal with Third Rock Ventures, LLC
         ("Third Rock"), and has and will continue to have substantial duties to
         Third Rock (including its portfolio companies). Adviser confirms that
         he has determined that Third Rock will not object to the services to be
         provided hereunder. Any services requested hereunder shall be scheduled
         so as not to interfere with Adviser's work at Third Rock (including
         work with Third Rock's portfolio companies). Adviser and represents
         that he believes he will be able to perform duties requested hereunder
         without significant conflict with his duties at Third Rock (or its
         portfolio companies). If at any time Adviser believes that his
         obligations under this Agreement could conflict in a material respect
         with his duties to Third Rock (or its portfolio companies), Adviser
         agrees to notify GLGC's CEO so that the parties can determine if there
         is a way to adjust his work under this Agreement so that it is not in
         conflict with his duties to Third Rock (and its portfolio companies).
         If such conflict cannot be resolved to the reasonable satisfaction of
         both parties to this Agreement, then either party may terminate this
         Agreement by written notice to the other.

     11. Miscellaneous:

              a.  Independent Contractor. For the purposes of this Agreement,
                  Adviser shall be an independent contractor without the
                  authority to bind or act as agent for GLGC or its employees
                  for any purpose. All taxes and social security payments due
                  with respect to any compensation paid pursuant to this
                  Agreement shall be the sole responsibility of Adviser.

              b.  Assignment. This Agreement is a contract for personal services
                  by Adviser in recognition of his special expertise and
                  experience; the performance of such personal services may not
                  be assigned or delegated.

              c.  Governing Law. This Agreement shall be construed in accordance
                  with the laws of the State of Maryland. Adviser hereby
                  expressly consents to the personal jurisdiction of the state
                  and federal courts located in Maryland for any lawsuit filed
                  there against him/her by GLGC arising from or relating to this
                  Agreement

              d.  Warranties. The parties warrant and represent that they have
                  the right to enter into this Agreement. Adviser further
                  warrants and represents that the terms of this Agreement are
                  not inconsistent with other contractual obligations, express
                  or implied, which he may have.

              e.  Amendments. No modification to this Agreement shall be
                  effective unless made in writing and duly executed by or on
                  behalf of each party.

              f.  Entire Agreement. This Agreement constitutes the entire
                  agreement between the parties with respect to the services to
                  be provided by Adviser hereunder superseding all prior
                  agreements and understandings between the parties (whether
                  written or oral) relating to said subject matter. However,
                  this Agreement does not modify, waive or alter any of the
                  obligations of the parties under prior agreements relating to
                  the previous employment of Adviser by GLGC.


<PAGE>

              g.  Counterparts. This Agreement may be executed in two or more
                  counterparts, including by facsimile transmission, each of
                  which shall be deemed an original, but all of which together
                  shall constitute one and the same instrument.

IN WITNESS WHEREOF, the parties have executed this Agreement as of the dates set
forth below.

               Gene Logic Inc.                         Louis Tartaglia

By:    /s/ Charles L. Dimmler, III            /s/ Louis A. Tartaglia
       ----------------------------------     ----------------------------------
       Charles L. Dimmler, III, President

Date:  September 19, 2007                     Date   September 21, 2007